$SKLZ
Skillz Inc.

2023 Q3 Form 10-Q Financial Statement

#000162828023037874 Filed on November 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3
Revenue $36.43M
YoY Change -39.55%
Cost Of Revenue $3.693M
YoY Change -51.12%
Gross Profit $32.73M
YoY Change -37.89%
Gross Profit Margin 89.86%
Selling, General & Admin $56.31M
YoY Change -21.84%
% of Gross Profit 172.04%
Research & Development $7.852M
YoY Change -6.01%
% of Gross Profit 23.99%
Depreciation & Amortization $490.0K
YoY Change -89.32%
% of Gross Profit 1.5%
Operating Expenses $64.17M
YoY Change -20.2%
Operating Profit -$31.43M
YoY Change 13.44%
Interest Expense $2.279M
YoY Change -159.86%
% of Operating Profit
Other Income/Expense, Net $48.00K
YoY Change -88.79%
Pretax Income -$33.54M
YoY Change -57.37%
Income Tax $10.00K
% Of Pretax Income
Net Earnings -$33.55M
YoY Change -57.29%
Net Earnings / Revenue -92.09%
Basic Earnings Per Share -$1.57
Diluted Earnings Per Share -$1.57
COMMON SHARES
Basic Shares Outstanding 21.31M shares
Diluted Shares Outstanding 21.31M shares

Balance Sheet

Concept 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $335.0M
YoY Change -27.95%
Cash & Equivalents $330.2M
Short-Term Investments $4.800M
Other Short-Term Assets $792.0K
YoY Change -95.71%
Inventory
Prepaid Expenses $4.483M
Receivables $9.265M
Other Receivables $0.00
Total Short-Term Assets $350.5M
YoY Change -28.83%
LONG-TERM ASSETS
Property, Plant & Equipment $13.80M
YoY Change -33.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $57.70M
YoY Change -61.25%
Other Assets $3.182M
YoY Change -14.58%
Total Long-Term Assets $77.62M
YoY Change -72.28%
TOTAL ASSETS
Total Short-Term Assets $350.5M
Total Long-Term Assets $77.62M
Total Assets $428.1M
YoY Change -44.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.395M
YoY Change -51.1%
Accrued Expenses $37.20M
YoY Change 1428.35%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $64.80M
YoY Change 21.75%
LONG-TERM LIABILITIES
Long-Term Debt $123.5M
YoY Change -54.58%
Other Long-Term Liabilities $1.167M
YoY Change -92.18%
Total Long-Term Liabilities $135.6M
YoY Change -52.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $64.80M
Total Long-Term Liabilities $135.6M
Total Liabilities $200.4M
YoY Change -41.08%
SHAREHOLDERS EQUITY
Retained Earnings -$959.0M
YoY Change 35.64%
Common Stock $41.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $227.7M
YoY Change
Total Liabilities & Shareholders Equity $428.1M
YoY Change -44.57%

Cashflow Statement

Concept 2023 Q3
OPERATING ACTIVITIES
Net Income -$33.55M
YoY Change -57.29%
Depreciation, Depletion And Amortization $490.0K
YoY Change -89.32%
Cash From Operating Activities -$18.43M
YoY Change -15.34%
INVESTING ACTIVITIES
Capital Expenditures $460.0K
YoY Change -128.55%
Acquisitions
YoY Change
Other Investing Activities $24.45M
YoY Change -75.87%
Cash From Investing Activities $23.98M
YoY Change -75.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -440.0K
YoY Change -94.57%
NET CHANGE
Cash From Operating Activities -18.43M
Cash From Investing Activities 23.98M
Cash From Financing Activities -440.0K
Net Change In Cash 5.110M
YoY Change -92.69%
FREE CASH FLOW
Cash From Operating Activities -$18.43M
Capital Expenditures $460.0K
Free Cash Flow -$18.89M
YoY Change -6.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Operating Income Loss
OperatingIncomeLoss
-282131000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
2279000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-62611000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
248729000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
699000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-14020000 usd
sklz Increase Decrease In Loss Contingency Accrual
IncreaseDecreaseInLossContingencyAccrual
-4605000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
4800000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9265000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7177000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6275000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4722000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
350498000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
501683000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
13812000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2133000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
60934000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
45666000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
64798000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
49495000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10874000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 usd
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2920000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2920000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3182000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
852000 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
119612000 usd
CY2023Q3 us-gaap Assets
Assets
428119000 usd
CY2022Q4 us-gaap Assets
Assets
621295000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2395000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1696000 usd
CY2023Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
11000 usd
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
289000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
123535000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
272781000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1167000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8387000 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
135587000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
293399000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
200385000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
342894000 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
31000000 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
41000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
41000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
120975000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
222837000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
3693000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
7599000 usd
us-gaap Cost Of Revenue
CostOfRevenue
11923000 usd
us-gaap Cost Of Revenue
CostOfRevenue
25802000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7852000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7937000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24757000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
44840000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
31925000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
51480000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
99510000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
242556000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24389000 usd
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.57
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.57
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.02
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.02
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21305470 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21305470 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20691704 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20691704 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
254386000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-14.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-14.48
CY2023Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.05
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
127268000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
2991000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
472000 usd
CY2023Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
77621000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1469000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11942000 usd
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
31000000 shares
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20936000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
78080000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
140540000 usd
CY2023Q3 sklz Impairment Of Intangible Assets And Other Charges
ImpairmentOfIntangibleAssetsAndOtherCharges
0 usd
CY2022Q3 sklz Impairment Of Intangible Assets And Other Charges
ImpairmentOfIntangibleAssetsAndOtherCharges
51230000 usd
sklz Impairment Of Intangible Assets And Other Charges
ImpairmentOfIntangibleAssetsAndOtherCharges
455000 usd
sklz Impairment Of Intangible Assets And Other Charges
ImpairmentOfIntangibleAssetsAndOtherCharges
51230000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
67859000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
139182000 usd
us-gaap Costs And Expenses
CostsAndExpenses
214725000 usd
us-gaap Costs And Expenses
CostsAndExpenses
504968000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-31432000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-79966000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-93750000 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2553000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
15205000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2553000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
6360000 usd
us-gaap Interest Expense
InterestExpense
7486000 usd
us-gaap Interest Expense
InterestExpense
22113000 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-127000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5405000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
508000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
98000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
398000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33536000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-83345000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-85655000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-295888000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-120000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
193000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-488000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-33545000 usd
us-gaap Net Income Loss
NetIncomeLoss
-85848000 usd
us-gaap Net Income Loss
NetIncomeLoss
-295400000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-14.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-14.48
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21175797 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21175797 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20396317 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20396317 shares
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
135000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
139000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1526000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-2484000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
139000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2484000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33410000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-83086000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-84322000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-297884000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
609159000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
236000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
77879000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2046000 usd
CY2022Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
64000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-149564000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
535600000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
617000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13431000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-577000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
486460000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6058000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
139000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-83225000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
409432000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
278401000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
33000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10548000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
997000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-35593000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
37000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10622000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
394000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-16710000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-25000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12440000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
135000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-33545000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
227734000 usd
us-gaap Net Income Loss
NetIncomeLoss
-85848000 usd
us-gaap Net Income Loss
NetIncomeLoss
-295400000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1858000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15705000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
33610000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
97368000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
15205000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2553000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1815000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2930000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-839000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-2819000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-481000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-278000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5405000 usd
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
455000 usd
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
51230000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
17000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1145000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2088000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4597000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1883000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2247000 usd
sklz Increase Decrease In Loss Contingency Accrual
IncreaseDecreaseInLossContingencyAccrual
0 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1732000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-895000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
8255000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-16972000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-59486000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-166784000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
12081000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1957000 usd
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
2000000 usd
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
0 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
432873000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
121226000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
485565000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
56599000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
125306000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
163744000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
176041000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
807000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2044000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2005000 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
135855000 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
7540000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
46000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
852000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-136616000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10737000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-32358000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1480000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
333078000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
242772000 usd
us-gaap Interest Paid Net
InterestPaidNet
12261000 usd
us-gaap Interest Paid Net
InterestPaidNet
15420000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
200000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and the related disclosures at the date of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the periods presented. Estimates are used in several areas including, but not limited to, end user incentive program, stock-based compensation, valuation of common stock warrants and indirect tax liabilities. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities. Actual results could differ materially from these estimates.</span></div>
CY2023Q3 sklz Reduction Of Revenue End User Incentives
ReductionOfRevenueEndUserIncentives
6700000 usd
CY2022Q3 sklz Reduction Of Revenue End User Incentives
ReductionOfRevenueEndUserIncentives
10900000 usd
sklz Reduction Of Revenue End User Incentives
ReductionOfRevenueEndUserIncentives
21900000 usd
sklz Reduction Of Revenue End User Incentives
ReductionOfRevenueEndUserIncentives
40400000 usd
CY2023Q3 sklz Selling And Marketing Expense End User Incentives
SellingAndMarketingExpenseEndUserIncentives
15500000 usd
CY2022Q3 sklz Selling And Marketing Expense End User Incentives
SellingAndMarketingExpenseEndUserIncentives
21400000 usd
sklz Selling And Marketing Expense End User Incentives
SellingAndMarketingExpenseEndUserIncentives
48100000 usd
sklz Selling And Marketing Expense End User Incentives
SellingAndMarketingExpenseEndUserIncentives
87200000 usd
CY2023Q3 sklz Selling And Marketing Expense Engagement Marketing
SellingAndMarketingExpenseEngagementMarketing
16900000 usd
CY2022Q3 sklz Selling And Marketing Expense Engagement Marketing
SellingAndMarketingExpenseEngagementMarketing
23500000 usd
sklz Selling And Marketing Expense Engagement Marketing
SellingAndMarketingExpenseEngagementMarketing
51600000 usd
sklz Selling And Marketing Expense Engagement Marketing
SellingAndMarketingExpenseEngagementMarketing
97600000 usd
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
2900000 usd
CY2023Q3 us-gaap Cash
Cash
21948000 usd
CY2022Q4 us-gaap Cash
Cash
130068000 usd
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
308210000 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
232448000 usd
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
2920000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
2920000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
333078000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
365436000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist of cash, cash equivalents, restricted cash, and marketable securities. Although the Company deposits its cash with multiple well-established financial institutions, the deposits, at times, may exceed federally insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents. Marketable securities primarily consist of corporate debt securities, asset backed securities and debt instruments issued by foreign governments. The Company limits the amount of credit exposure to any one issuer and monitors the financial condition of the financial institutions on a regular basis.</span></div>
CY2023Q1 us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
11500000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11300000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q3 us-gaap Advertising Expense
AdvertisingExpense
9700000 usd
CY2022Q3 us-gaap Advertising Expense
AdvertisingExpense
18800000 usd
us-gaap Advertising Expense
AdvertisingExpense
26800000 usd
us-gaap Advertising Expense
AdvertisingExpense
109400000 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
57033000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1174271000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-925411000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
248729000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8025000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16906000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
32669000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
67587000 usd
CY2023Q2 sklz General And Administrative Expense Including Impairment Charges
GeneralAndAdministrativeExpenseIncludingImpairmentCharges
26074000 usd
sklz General And Administrative Expense Including Impairment Charges
GeneralAndAdministrativeExpenseIncludingImpairmentCharges
54144000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16596000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-52121000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
114000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
183000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-16710000 usd
us-gaap Net Income Loss
NetIncomeLoss
-52304000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-16710000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16710000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-52304000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-52304000 usd
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21143257 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21143257 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21109886 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21109886 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.79
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.79
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.48
us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
100000 usd
CY2023Q3 sklz Credit Card Processing Reserve Current
CreditCardProcessingReserveCurrent
1000000 usd
CY2022Q4 sklz Credit Card Processing Reserve Current
CreditCardProcessingReserveCurrent
1000000 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4483000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2234000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
792000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1488000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6275000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4722000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
0 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
10000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
23409000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
10819000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
9597000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
7828000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
13812000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
2991000 usd
CY2023Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3728000 usd
CY2022Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
4409000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8374000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4991000 usd
CY2023Q3 sklz Accrued Publisher Fees Current
AccruedPublisherFeesCurrent
2437000 usd
CY2022Q4 sklz Accrued Publisher Fees Current
AccruedPublisherFeesCurrent
4442000 usd
CY2023Q3 sklz Accrued End User Liability Current
AccruedEndUserLiabilityCurrent
6163000 usd
CY2022Q4 sklz Accrued End User Liability Current
AccruedEndUserLiabilityCurrent
8984000 usd
CY2023Q3 sklz Accrued Developer Revenue Share Current
AccruedDeveloperRevenueShareCurrent
1639000 usd
CY2022Q4 sklz Accrued Developer Revenue Share Current
AccruedDeveloperRevenueShareCurrent
2017000 usd
CY2023Q3 sklz Short Term Lease Obligation Current
ShortTermLeaseObligationCurrent
890000 usd
CY2022Q4 sklz Short Term Lease Obligation Current
ShortTermLeaseObligationCurrent
1525000 usd
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5249000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1984000 usd
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
7109000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
3877000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1236000 usd
CY2023Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
11908000 usd
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
10909000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9560000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5169000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
60934000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
45666000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
330200000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
362500000 usd
CY2023Q3 sklz Cash Cash Equivalents And Available For Sale Debt Securities Amortized Cost
CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost
315105000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
37000 usd
CY2023Q3 sklz Cash Cash Equivalents And Available For Sale Debt Securities
CashCashEquivalentsAndAvailableForSaleDebtSecurities
315068000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
308210000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
4800000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
2058000 usd
CY2022Q4 sklz Cash Cash Equivalents And Available For Sale Debt Securities Amortized Cost
CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost
504905000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
32000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1595000 usd
CY2022Q4 sklz Cash Cash Equivalents And Available For Sale Debt Securities
CashCashEquivalentsAndAvailableForSaleDebtSecurities
503342000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
319346000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
127268000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
56728000 usd
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
55600000 usd
CY2023Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
55600000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
0 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
0 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
6858000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
37000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
6858000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
37000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
108276000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
800000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
64117000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
795000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
172393000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
1595000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
4816000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
4800000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
2079000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2058000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
0 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
0 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
6895000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
6858000 usd
CY2023Q3 sklz Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Noncurrent
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNoncurrent
6136000 usd
CY2022Q4 sklz Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Noncurrent
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNoncurrent
16719000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
123535000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
272781000 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
3900000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
129671000 usd
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
129671000 usd
CY2021Q3 us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
11600000 usd
CY2021Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
7100000 usd
CY2022Q2 us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
4350000 usd
CY2022Q2 us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
4350000 usd
CY2023Q3 sklz Common Stock And Preferred Stock Shares Authorized
CommonStockAndPreferredStockSharesAuthorized
41000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
31000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12440000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6058000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33610000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
97368000 usd
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.05
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1422876 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
812293 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
263.00
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M7D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1145000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
1053433 shares
sklz Share Based Compensation Arrangement By Share Based Payment Award Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantsInPeriodGross
1089831 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
95911 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.53
sklz Share Based Compensation Arrangement By Share Based Payment Award Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresInPeriod
625955 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
11067 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
27.68
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2012433 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
705315 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
302.25
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M20D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
68000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
101001 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.24
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y2M23D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
67000 usd
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
604314 shares
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
351.22
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.57
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.57
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.02
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.02
sklz Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm
P7Y5M15D
CY2023Q3 sklz Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIntrinsicValue
1000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
78700000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
780000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
700000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
820000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
15900000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000.00 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-120000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0003
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0014
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0023
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0016
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33545000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-33545000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-83225000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-83225000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-85848000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-85848000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-295400000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-295400000 usd
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21305470 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21305470 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20691704 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20691704 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21175797 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21175797 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20396317 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20396317 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3619867 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1804465 shares
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36427000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
59216000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
120975000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
222837000 usd
CY2023Q3 us-gaap Noncurrent Assets
NoncurrentAssets
13812000 usd
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
3463000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
65000000 usd

Files In Submission

Name View Source Status
sklz-20230930_cal.xml Edgar Link unprocessable
0001628280-23-037874-index-headers.html Edgar Link pending
0001628280-23-037874-index.html Edgar Link pending
0001628280-23-037874.txt Edgar Link pending
0001628280-23-037874-xbrl.zip Edgar Link pending
ex311_fy23q3.htm Edgar Link pending
ex312_fy23q3.htm Edgar Link pending
ex321_fy23q3.htm Edgar Link pending
ex322_fy23q3.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
skillzinc-dexcertificate.htm Edgar Link pending
skillzinc-dexcertificate001.jpg Edgar Link pending
skillzinc-dexcertificate002.jpg Edgar Link pending
skillzinc-dexcertificate003.jpg Edgar Link pending
sklz-20230930.htm Edgar Link pending
sklz-20230930.xsd Edgar Link pending
sklz-20230930_def.xml Edgar Link unprocessable
sklz-20230930_lab.xml Edgar Link unprocessable
sklz-20230930_pre.xml Edgar Link unprocessable
sklz-20230930_htm.xml Edgar Link completed